La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
PeptiDream Résultats passés
Passé contrôle des critères 5/6
PeptiDream has been growing earnings at an average annual rate of 33.5%, while the Biotechs industry saw earnings growing at 12.5% annually. Revenues have been growing at an average rate of 39.6% per year. PeptiDream's return on equity is 36.9%, and it has net margins of 39.1%.
Informations clés
33.5%
Taux de croissance des bénéfices
32.8%
Taux de croissance du BPA
| Biotechs Croissance de l'industrie | 31.9% |
| Taux de croissance des recettes | 39.6% |
| Rendement des fonds propres | 36.9% |
| Marge nette | 39.1% |
| Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
PeptiDream Inc. Just Beat Revenue Estimates By 13%
Aug 12
PeptiDream Inc. (TSE:4587) Surges 27% Yet Its Low P/S Is No Reason For Excitement
Jun 30News Flash: Analysts Just Made A Meaningful Upgrade To Their PeptiDream Inc. (TSE:4587) Forecasts
Jun 02PeptiDream Inc.'s (TSE:4587) 42% Price Boost Is Out Of Tune With Revenues
Apr 30Is PeptiDream Inc. (TSE:4587) Trading At A 46% Discount?
Apr 29PeptiDream Inc.'s (TSE:4587) 25% Jump Shows Its Popularity With Investors
Mar 03Ventilation des recettes et des dépenses
Comment PeptiDream gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 55,419 | 21,689 | 7,049 | 3,120 |
| 31 Mar 24 | 27,974 | 2,441 | 6,857 | 3,137 |
| 31 Dec 23 | 28,712 | 3,035 | 6,673 | 3,155 |
| 30 Sep 23 | 38,187 | 11,281 | 6,970 | 3,286 |
| 30 Jun 23 | 31,254 | 7,956 | 6,845 | 3,257 |
| 31 Mar 23 | 31,396 | 8,135 | 6,833 | 3,229 |
| 31 Dec 22 | 26,852 | 7,554 | 5,830 | 2,915 |
| 30 Sep 22 | 12,811 | 57 | 4,944 | 1,888 |
| 30 Jun 22 | 11,511 | 1,705 | 3,862 | 1,164 |
| 31 Mar 22 | 8,326 | 2,341 | 2,759 | 394 |
| 31 Dec 21 | 9,366 | 3,606 | 2,590 | 0 |
| 30 Sep 21 | 15,607 | 7,110 | 2,693 | 0 |
| 30 Jun 21 | 11,449 | 4,329 | 2,623 | 0 |
| 31 Mar 21 | 12,743 | 5,226 | 2,527 | 0 |
| 31 Dec 20 | 11,677 | 4,448 | 2,538 | 0 |
| 31 Dec 19 | 2,075 | -977 | 2,506 | 0 |
| 30 Jun 19 | 7,217 | 2,770 | 1,986 | 0 |
| 30 Jun 18 | 6,427 | 2,335 | 1,737 | 0 |
| 31 Mar 18 | 4,616 | 895 | 1,797 | 0 |
| 30 Sep 17 | 4,271 | 962 | 1,647 | 0 |
| 30 Jun 17 | 4,896 | 1,891 | 1,046 | 0 |
| 31 Mar 17 | 3,064 | 769 | 826 | 0 |
| 31 Dec 16 | 4,457 | 1,685 | 764 | 0 |
| 30 Sep 16 | 4,735 | 1,823 | 739 | 0 |
| 30 Jun 16 | 4,328 | 1,581 | 694 | 0 |
| 31 Mar 16 | 4,620 | 1,976 | 603 | 0 |
| 31 Dec 15 | 3,121 | 1,203 | 481 | 0 |
| 30 Sep 15 | 2,722 | 1,063 | 409 | 0 |
| 30 Jun 15 | 2,474 | 1,004 | 362 | 0 |
| 31 Mar 15 | 757 | 46 | 310 | 0 |
| 31 Dec 14 | 739 | 67 | 307 | 0 |
| 30 Sep 14 | 786 | 118 | 301 | 0 |
| 30 Jun 14 | 819 | 149 | 303 | 0 |
Des revenus de qualité: 4587 has a high level of non-cash earnings.
Augmentation de la marge bénéficiaire: 4587's current net profit margins (39.1%) are higher than last year (25.5%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 4587's earnings have grown significantly by 33.5% per year over the past 5 years.
Accélération de la croissance: 4587's earnings growth over the past year (172.6%) exceeds its 5-year average (33.5% per year).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices 4587 au cours de l'année écoulée ( 172.6% ) a dépassé celle du secteur Biotechs 172.6%.
Rendement des fonds propres
ROE élevé: 4587's Return on Equity (36.9%) is considered high.